Cargando…

Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival

SIMPLE SUMMARY: Malignant melanoma is the most lethal skin cancer due to its aggressive clinical behavior and therapeutic resistance. A comprehensive knowledge of the molecular mechanisms underlying melanoma progression is urgently needed to improve the survival of melanoma patients. Phenotypic plas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Naharro, Alberto, Bustos-Tauler, José, Floristán, Alfredo, Yuste, Lourdes, Oltra, Sara S., Vinyals, Antònia, Moreno-Bueno, Gema, Fabra, Àngels, Portillo, Francisco, Cano, Amparo, Santamaría, Patricia G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909883/ https://www.ncbi.nlm.nih.gov/pubmed/35267510 http://dx.doi.org/10.3390/cancers14051200

Ejemplares similares

Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022)

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
por: Moreno-Bueno, Gema, et al.
Publicado: (2011)

LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
por: Cuevas, Eva P., et al.
Publicado: (2014)

Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability
por: Santamaría, Patricia G., et al.
Publicado: (2017)

LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway
por: Cuevas, Eva P., et al.
Publicado: (2017)

LOXL2 in Cancer: A Two-Decade Perspective
por: Cano, Amparo, et al.
Publicado: (2023)

Contribution of Epithelial Plasticity to Therapy Resistance
por: Santamaría, Patricia G., et al.
Publicado: (2019)

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
por: Alonso-Nocelo, Marta, et al.
Publicado: (2023)

EMT: Present and future in clinical oncology
por: Santamaria, Patricia G., et al.
Publicado: (2017)

E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer
por: López-Menéndez, Celia, et al.
Publicado: (2021)

New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins
por: Eraso, Pilar, et al.
Publicado: (2023)

Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT
por: Hu, Qingjiang, et al.
Publicado: (2020)

Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation
por: Kober, Katharina Isabelle, et al.
Publicado: (2018)

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)

The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)

Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese
por: Lee, Kelvin Y.C., et al.
Publicado: (2009)

LOXL2 as a protective in osteoarthritis cartilage
por: Bais, Manish V., et al.
Publicado: (2017)

Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020)

LOXL2 Inhibitors and Breast Cancer Progression
por: Ferreira, Sandra, et al.
Publicado: (2021)

Cleavage of LOXL1 by BMP1 and ADAMTS14 Proteases Suggests a Role for Proteolytic Processing in the Regulation of LOXL1 Function
por: Rosell-García, Tamara, et al.
Publicado: (2022)

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
por: Díaz-López, Antonio, et al.
Publicado: (2014)

LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019)

Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020)

LAMA2 and LOXL4 are candidate FSGS genes
por: Vijayan, Poornima, et al.
Publicado: (2021)

Insight updating of the molecular hallmarks in ovarian carcinoma
por: Mota, Alba, et al.
Publicado: (2020)

Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population
por: Chiras, Dimitrios, et al.
Publicado: (2013)

Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese
por: Fuse, Nobuo, et al.
Publicado: (2008)

Evaluation of LOXL1 polymorphisms in exfoliation syndrome in the Uygur population
por: Mayinu,, et al.
Publicado: (2011)

Emerging role of LOXL2 in the promotion of pancreas cancer metastasis
por: Park, Joon Seong, et al.
Publicado: (2016)

Association of LOXL1 Gene Polymorphisms with Exfoliation Glaucoma Patients
por: TAGHAVI, Elham, et al.
Publicado: (2019)

LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
por: Yuan, Ruiyan, et al.
Publicado: (2021)

E47 and Id1 Interplay in Epithelial-Mesenchymal Transition
por: Cubillo, Eva, et al.
Publicado: (2013)

Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma
por: Aragon-Martin, Jose A., et al.
Publicado: (2008)

LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population
por: Mori, Kazuhiko, et al.
Publicado: (2008)

Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population
por: Chen, Ling, et al.
Publicado: (2009)

Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
por: Yang, Jin, et al.
Publicado: (2016)

Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
por: Park, Pil-Gu, et al.
Publicado: (2017)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling
por: Zhang, Caixia, et al.
Publicado: (2021)

Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma
por: Challa, Pratap, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5bdi8ibjvdpmjaqe4ei7fdf5te